
Sign up to save your podcasts
Or


Layoffs in biopharma show no signs of slowing, with workforce reductions holding steady across the first two quarters of 2025.
In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Park and Fierce Biotech Senior Editor Gabrielle Masson break down the latest layoff trends and how they compare to last year.
Tune in for a look at the numbers so far, the pace of biotech closures and how federal policy shifts are affecting the industry.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
By Fierce Life Sciences4.1
1212 ratings
Layoffs in biopharma show no signs of slowing, with workforce reductions holding steady across the first two quarters of 2025.
In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Park and Fierce Biotech Senior Editor Gabrielle Masson break down the latest layoff trends and how they compare to last year.
Tune in for a look at the numbers so far, the pace of biotech closures and how federal policy shifts are affecting the industry.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.

3,217 Listeners

1,720 Listeners

4,345 Listeners

2,201 Listeners

406 Listeners

1,967 Listeners

353 Listeners

1,657 Listeners

145 Listeners

96 Listeners

3,976 Listeners

1,425 Listeners

337 Listeners

34 Listeners

170 Listeners